News Pfizer's rituximab biosimilar gets late-stage trial boost Phase 3 success sets up showdown with Roche, Sandoz, and Celltrion
News Biotech association steps in to fight growth of ‘plausibilit... The UK’s Supreme Court is to allow the UK BioIndustry Association (BIA) to intervene in a long-running legal battle over a drug patent.
News Pharma collaborates to improve chances of NICE backing Duche... Project will initially focus on DMD but could benefit other rare diseases
News Bad week for dementia R&D after Axovant howler and another f... Axovant misreports trial results, Lundbeck Alzheimer's drug fails
News A Pfizer consumer buyout won't detract from pharma business,... Walmsley has axed 40% of management team in shake-up
News Pfizer axes Alzheimer's and Parkinson's research Big pharma will continue developing tanezumab painkiller with Lilly
News CMS aims for broader GLP-1 access via federal programmes CMS has revealed a new, voluntary access programme that aims to broaden the use of GLP-1 agonist medicines for diabetes and obesity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
